SC 3: Technical Development of T Cell-Based Immunotherapies – Considerations and Lessons Learned

ABOUT THIS COURSE:

During the development of multiple T cell based cellular immunotherapies at Immatics, many experiences have been gained and lessons learned. The workshop will focus on the various aspects of process development and GMP manufacturing of these T cell products including starting cell or tissue, raw material including viral vectors, manufacturing systems, assay development and validation, release testing specification, as well as the regulatory aspects involved.

INSTRUCTOR BIO

Ali Mohamed, PhD, Vice President, CMC, Immatics US Inc. Formerly the senior director of manufacturing operations/ manufacturing development at PCT (Now HCATS). Dr. Mohamed has nearly 20 years of experience in process development and GMP manufacturing of regenerative medicine, cell and gene therapy products at various CMOs and clinical stage companies including Lonza, Osiris Therapeutics, and AlloCure. The speaker holds a PhD in Molecular Pharmacology from Medical College of Ohio and postdoctoral fellowship in neuroscience and neurobiology from the Georgetown University.